<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04873557</url>
  </required_header>
  <id_info>
    <org_study_id>CUPRIC001</org_study_id>
    <nct_id>NCT04873557</nct_id>
  </id_info>
  <brief_title>Copper Use as Protection Against Antimicrobial Resistance in the ICU</brief_title>
  <acronym>CUPRIC</acronym>
  <official_title>Copper Use as Protection Against Antimicrobial Resistance in the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad del Desarrollo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad del Desarrollo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CUPRIC is an investigator initiated and conducted, prospective, quasi-experimental study to&#xD;
      determine whether the combined use of copper-alloyed objects plus copper-enriched textiles&#xD;
      reduce the burden of MDRO colonization and HAIs incidence in the critically ill population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Healthcare-associated infections (HAI) are among the leading causes of&#xD;
      preventable death and are associated with significant financial costs. Treatment of HAI has&#xD;
      been complicated by the rise of antimicrobial resistance (AMR). AMR limits the number of&#xD;
      effective antibiotics available to treat HAI. Therefore, the prevention of these infections&#xD;
      is increasingly important. Current evidence indicates that patients' colonization with&#xD;
      multidrug-resistant organisms (MDRO) is a critical issue with the potential of causing&#xD;
      serious harm. Fortunately, newer strategies such as copper usage in the healthcare&#xD;
      environment are under development and these approaches may decrease the burden of MDRO&#xD;
      without disrupting gastrointestinal colonization resistance. This project will explore a&#xD;
      cutting-edge strategy to decrease HAIs through the reduction of environmental reservoirs by&#xD;
      replacement of high-touch surfaces and textiles in an intensive care unit (ICU) setting using&#xD;
      the inherent antimicrobial properties of copper alloys. By studying the incidence of MDRO&#xD;
      colonization of patients and rates of HAIs in patients exposed and unexposed to copper-based&#xD;
      surfaces and textiles, the aim is to expand knowledge, to help optimize the practice of the&#xD;
      application of antimicrobial surfaces in the ICU setting.&#xD;
&#xD;
      AIM: To establish the efficacy of the combined use of copper alloy-surfaced objects and&#xD;
      copper-enriched textiles to reduce the burden of patients' MDRO colonization in the ICU.&#xD;
&#xD;
      METHODS: The investigators will conduct a prospective, quasi-experimental study in the ICU at&#xD;
      the Hospital Regional de Iquique. During the first stage of the study (6 months), the&#xD;
      investigators will determine the cumulative incidence of MDRO acquisition (primary outcome)&#xD;
      and the incidence rate of HAIs in patients admitted to the ICU before installation of the&#xD;
      antimicrobial copper products. During the second stage (6 months), the investigator will&#xD;
      assess study outcomes after the installation of copper surfaces over highly touched surfaces&#xD;
      within the patient unit.&#xD;
&#xD;
      EXPECTED RESULTS: It is expected a 30% reduction of the cumulative incidence of MDRO&#xD;
      acquisition with respect to the control group. The investigators also expect this reduction&#xD;
      to translate into a decrease of HAIs in the treatment versus the control group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MDRO acquisition</measure>
    <time_frame>12 months</time_frame>
    <description>To determine the cumulative incidence of MDRO acquisition in patients admitted to the ICU before and after installation of antimicrobial copper surfaces and copper-enriched textiles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence Rate of HAIs</measure>
    <time_frame>12 months</time_frame>
    <description>To determine the incidence rate of HAIs in patients admitted to the ICU before and after installation of antimicrobial copper surfaces and copper-enriched textiles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of acquisition of individual bacterial organisms</measure>
    <time_frame>12 months</time_frame>
    <description>To determine the cumulative incidence of acquisition of individual bacterial organisms of interest before and after installation of antimicrobial copper surfaces and copper-enriched textiles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual HAI development</measure>
    <time_frame>12 months</time_frame>
    <description>To determine the cumulative incidence of development of each of the included HAIs separately (See 3.2.1), before and after installation of antimicrobial copper surfaces and copper-enriched textiles.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Healthcare Associated Infection</condition>
  <arm_group>
    <arm_group_label>Copper Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention with copper-based surfaces plus copper-enriched linen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group without copper intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Copper-based surfaces plus copper-enriched linen</intervention_name>
    <description>We will assess the efficacy of our intervention to decrease the acquisition of nasal and intestinal colonization with MDROs and the development of HAIs in the ICU setting.</description>
    <arm_group_label>Copper Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults (age ≥18 years)&#xD;
&#xD;
          2. ≥ 72 h in the ICU&#xD;
&#xD;
          3. Provide informed consent (or via an appropriate proxy, according to local&#xD;
             requirements).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        (a) Patients with conditions that preclude rectal or nasal sampling, such as total&#xD;
        colectomy with a colostomy bag, facial surgery/trauma with nasal involvement, among others.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose M Munita, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad del Desarrollo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francisco J Moya-Flores, PHD</last_name>
    <phone>+56934233740</phone>
    <email>fmoya@wisc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria de los Angeles Spencer, MS</last_name>
    <phone>+56991389918</phone>
    <email>mspencers@udd.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Regional de Iquique</name>
      <address>
        <city>Iquique</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Iriondo, MD</last_name>
      <email>director@hospitaliquique.cl</email>
    </contact>
    <investigator>
      <last_name>Juan Moreno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicole Villarroel, MSN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <reference>
    <citation>Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections - an overview. Infect Drug Resist. 2018 Nov 15;11:2321-2333. doi: 10.2147/IDR.S177247. eCollection 2018. Review.</citation>
    <PMID>30532565</PMID>
  </reference>
  <reference>
    <citation>Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013 May;34(5):479-86. doi: 10.1086/670207.</citation>
    <PMID>23571364</PMID>
  </reference>
  <reference>
    <citation>Schmidt MG, von Dessauer B, Benavente C, Benadof D, Cifuentes P, Elgueta A, Duran C, Navarrete MS. Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit. Am J Infect Control. 2016 Feb;44(2):203-9. doi: 10.1016/j.ajic.2015.09.008. Epub 2015 Nov 6.</citation>
    <PMID>26553403</PMID>
  </reference>
  <reference>
    <citation>Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ. The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay. Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00757-19. doi: 10.1128/AAC.00757-19. Print 2019 Aug.</citation>
    <PMID>31138574</PMID>
  </reference>
  <reference>
    <citation>Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control. 2005 Sep;33(7):385-91.</citation>
    <PMID>16153484</PMID>
  </reference>
  <reference>
    <citation>Sickbert-Bennett EE, DiBiase LM, Willis TM, Wolak ES, Weber DJ, Rutala WA. Reduction of Healthcare-Associated Infections by Exceeding High Compliance with Hand Hygiene Practices. Emerg Infect Dis. 2016 Sep;22(9):1628-30. doi: 10.3201/eid2209.151440.</citation>
    <PMID>27532259</PMID>
  </reference>
  <reference>
    <citation>Karpanen TJ, Casey AL, Lambert PA, Cookson BD, Nightingale P, Miruszenko L, Elliott TS. The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Infect Control Hosp Epidemiol. 2012 Jan;33(1):3-9. doi: 10.1086/663644. Epub 2011 Dec 7.</citation>
    <PMID>22173515</PMID>
  </reference>
  <reference>
    <citation>Madden GR, Heon BE, Sifri CD. Effect of copper-impregnated linens on multidrug-resistant organism acquisition and Clostridium difficile infection at a long-term acute-care hospital. Infect Control Hosp Epidemiol. 2018 Nov;39(11):1384-1386. doi: 10.1017/ice.2018.196. Epub 2018 Sep 20.</citation>
    <PMID>30231949</PMID>
  </reference>
  <reference>
    <citation>Schmidt MG, Attaway HH, Sharpe PA, John J Jr, Sepkowitz KA, Morgan A, Fairey SE, Singh S, Steed LL, Cantey JR, Freeman KD, Michels HT, Salgado CD. Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol. 2012 Jul;50(7):2217-23. doi: 10.1128/JCM.01032-12. Epub 2012 May 2.</citation>
    <PMID>22553242</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad del Desarrollo</investigator_affiliation>
    <investigator_full_name>Jose M Munita</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Healthcare Associated Infection</keyword>
  <keyword>Multidrug-Resistant Organism</keyword>
  <keyword>Carbapenem-resistant Enterobacterial</keyword>
  <keyword>Methicillin-resistant Staphylococcus aureus</keyword>
  <keyword>Vancomycin-Resistant Enterococcus</keyword>
  <keyword>Intensive Care Unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Copper</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

